Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Sustainability
The Rise of ESG: Where It Is Now and How It Got Here
Calls for corporate reform are as old as the corporation itself, so why now are companies pushing for more ESG efforts in their organizations?
By
Ted Jackson
| July 5, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Humira
M&A
Botox Maker Allergan Sold to AbbVie for $63B
AbbVie faces pressure to diversify its portfolio as Humira, the world’s best-selling drug, faces increased competition from cheaper versions in Europe.
By
Lauren Muskett
| June 25, 2019
Read More
Tax
Treasury Stance Regardless, Another Tax-Inversion Deal Pops Up
AbbVie's plans to pay less taxes by relocating to Britain after buying Shire touches a raw nerve in Washington.
By
Iris Dorbian
| July 19, 2014
Read More